IDEVvsXBI
iShares Core MSCI International Developed Markets ETF against SPDR S&P Biotech ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IDEV | XBI | |
|---|---|---|
| Expense ratio | 0.040% | 0.35% |
| Assets | $32.2B | $10.4B |
| Net flow, 1 month | +$614M | −$690M |
| Net flow, 1 year | +$7B | +$1.1B |
| Return, YTD | +7.5% | +26.7% |
| Return, 1 year | +9.9% | +52.4% |
| Avg daily volume | 1.8M | 8.6M |
| Holdings | 2281 | 135 |
| Listed | Mar 21, 2017 | Jan 31, 2006 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS